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858-5 Effect of Gender on the Outcome of Patients With 
Severe Heart Failure Treated With Carvedlloh Results of 
the COPERNICUS Study 
Michal P. Tendera. Andrew J. Coats, Michael B. Fowler, Hugo A. Katus, Paul Mohacsi, 
Jean L. Rouleau, Henry Krum, Ildiko Amann-Zalan, Nell H. Shusterman, Ellen B. 
Roecker, Milton Packer, for the COPERNICUS Study, Silesian School of Medicine, 
Katowice, Poland. 
Background: The results of the MERIT-HF trial suggested that women with heart failure 
(HF) respond less favorably to ~-blockade than men. To further explore this observation, 
we evaluated the effect of gender on the response to carvedilol (CRV) in the COPERNI- 
CUS trial. 
Methods: 2289 patients (1824 men, 465 women) with symptoms of CHF at rest or on 
minimal exertion and ejection fraction <25% were randomly assigned to placebo (PBO) 
or CRV for up to 29 months. Women were older than men (66 vs 63 yrs; P<0,001) and 
were more likely to have non-ischemic HF (42% vs 30%; P<0.001) but were similar in 
other baseline characteristics. 
Results: Shown below are Cox model (CRV:PBO) hazard ratios, 95% CI and interaction 
P values: 
Men Women Interaction 
P value 
All-cause mortality 0.65 (0.51-0.83) 0.65 (0.39-1.11) 0.98 
Death or any hospitalization 0.79 (0.68-0.91) 0,67 (0.51-0.89) 0.98 
Death or cardiovascular hospitalization 0.76 (0.65-0.90) 0.60 (0.43-0.84) 0.21 
Death or HF hospitalization 0.73 (0.61-0.87) 0.57 (0.40-0.81) 0.20 
Gender did not influence the frequency of adverse effects attributable to CRV (e.g., 
bradycardia). However, when compared with PBO, men treated with CRV were 11% less 
likely and women treated with CRV were 27% less likely to experience a serious adverse 
event (interaction P = 0.10). The risk of permanent withdrawal was lower with CRV than 
with PBO in both sexes (relative risk in women = 0.56 [95% CI, 0.33-0.96]; relative risk in 
men = 0.82 [95% CI, 0.65-1.05], interaction P=0.21). 
Conclusion: In COPERNICUS women with severe HF experienced similar clinical bene- 
fits and tolerated treatment with CRY as well as men. 
11:45 a.m. 
858-6 Advanced Heart Failure Patients Unable to Reach ACE 
Inhibitor Targets: A High Risk Population Identified 
During Hospitalization 
Monica R. Shah. Vic Hasselblad, Lynne W. Stevenson, Wendy A. Gattis, Mihai 
Gheorghiade, Robert M. Catiff, Christopher M. O'Connor, Duke Clinical Research 
Institute, Durham, North Carolina, Brigham and Women's Hospital, Boston, 
Massachusetts. 
Background-ACE inhibitors (ACEI) are generally prescribed to patients with advanced 
heart failure (HF) in doses lower than shown effective in clinical trials. We sought to 
define the advanced HF population in which ACEI could not be titrated to target doses. 
Methods-The Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbation 
of Chronic Congestive Heart Failure (OPTIME-CHF) enrolled 949 patients with NYHA 
class Ill-IV HF. Achieving target doses of ACEI was a predefined endpoint of the trial. 
Results-Patients unable to reach >50% ACEI target doses were older, had lower systolic 
blood pressure (BP), and higher creatinine. Clinical features of the patients are shown 
(Table). Advanced HF patients discharged on <50% ACEI had a significantly higher rate 
of death or hospitalization at 60 days than did patients taking >50% ACEI target doses, 
even after adjustment for age, NYHA class, ejection fraction (EF), creatinine, and systolic 
BP (odds ratio, 1.48; 95% CI, 1.04-2.10; p=0.03). Conclusions-Even after adjusting for 
clinical factors that contdbute both to low ACEI dosing and higher mortality, patients on 
<50% ACEI target doses had worse outcomes. This suggests an inability to tolerate 
>50% ACEi target doses defines a large subgroup of advanced HF patients with worse 
prognosis that may require new treatment strategies. 
Clinical Features of Patients on Low vs High Dose ACEI 
Clinical Feature (median,<50% ACEI Target Dose>50% ACEI Target Dose p value 
interquartlle range) (n=305) (n--422) 
Age, y 7t (60, 78) 61 (51, 73) 0.0001 
SBP, mmHg 114 (102, 131) 123 (110, 136) 0.0001 
Creatlnlne, mg/dL 1.4 (1.1, 1.7) 1.3 (1, 1.6) 0,007 
Death or hosp, % 39.3% 28.1% 0.002 
ABSTRACTS - Cardiac Function and Heart Failure 185A 
POSTER SESSION 
1181 Genes and Heart Failure Hypertrophy 
Tuesday, March 19, 2002, Noon-2:00 p.m. 
Georgia World Congress Center, Hall G 
Presentation Hour: Noon- l :00  p.m. 
1181-141 NOS3 Deficiency Is Associated With a Shi f t  Toward Pro- 
Oxidant Gene Expression In Murlne Myocardium 
Thomas P, Caooola, Brian Rah, Sarfraz A. Durrani, Amy Cemetich, Dan E. Berkowitz, 
Eric Hoffman, Joshua M Hare, NHLBI Program in Geoomic Applications--Hopgene, 
Johns Hopkins University, Baltimore, Maryland, Center for Genetic Medicine, Children's 
National Medical Center, Washington, DisL of Columbia. 
Background: Inhibition or transgenic detetion of NOS3 has adverse effects on contrac- 
tile function in vitro, and leads to hypertension and leff ventricular hypertrophy in vivo. A 
large body of data indicates that nitric oxide (NO) exerts many of its effects by interacting 
with a complex network of redox signaling pathways. Using a genomic approach, we 
tested the hypothesis that NOS3 deficiency leads to compensatory changes in the 
expression of redox genes in murine myocardium. 
Methods: Myocardial RNA was isolated from NOS3 "/" mice and their appropriate C57BI/ 
6 controls (n=3 each, age 4.0 +/- 0.5 mos.; Tdzol reagent extraction method). Within 
each group, samples were combined in equimolar amounts resulting in single NOS3 "/" 
and control RNA pools. Duplicate in vitro transcriptions were performed on each pool to 
form 2 NOS3 "/" and 2 control cRNA probes that were each hybridized with a murine 
Affymetrix MG74A chip containing ~6,000 genes and -6000 ESTs. Relative expression 
of a predefined group of oxidases, the superoxide dismutases (SOD), catalase, and 
members of the glutathione pathway were compared among the NOS3 "/" and control 
pools. Statistical significance was determined using a Monte-Carlo method. 
Results: Of the 40 genes examined, seven were under-expressed in NOS3 "/" myooar- 
dium, including mitochondrial and cytosolic SOD, glutathione transferase, and five 
nuclear-encoded subunits of cyctoohrome C oxidase (complex IV). In contrast, only 
extracallular SOD was over-expressed. 
Conclusions: These data indicate a shift in myocardial gane transcription toward a pro- 
oxidant state in the absence of NOS3. In addition to increasing ventricular afterload, 
NOS3 deficiency may promote ventricular hypertrophy by promoting oxidative stress 
within the myooardium. 
1181-142 Compensatory  Electr ical  Remode l ing  in Hearts of  
Transgenic Mice That Overexpress the Ca2+ Channel 
Alpha 1C Subunit 
Ilona Bodi, James N. Muth, Gyula Varadi, Natasha N. Petrashevskaya, Arnold Schwartz, 
University of Cincinnati, Cincinnati, Ohio. 
Background: Prolongation of the action potential duration (APD) and a reduction of the 
transient outward K + current (Ito) are thought o be hallmarks of hypertrophy. A model in 
which the c( 1 subunit of the L-voltage-dependent calcium channel is over-expressed in 
transgenic mice offers an opportunity to study this phenomenon in detail. 
Methods: We used the whole-cell patch-clamp technique, radioligand binding and retro- 
grade perfused hearts to characterize this model at the cell and organ level. 
Results: Electrophysiological analysis in ventricular myocytes isolated from transgenic 
(Tg) and nontransgsnic (Ntg) mice at 4-month of age (mild hypertrophy) demonstrated a 
slight decrease in the APD at 90% repoladzation (APD90) and an up-regulation of the L- 
type Ca2+-current and dihydropyridine binding. The changes were accompanied by a 
small increase in Ito density without altering the staady-state inactivation. No change was 
detected in the protein expression level of Kv4.3 and 4.2 up to 8-months of age. Kvl.4 
was up-regulated in Tg hearts from 8-month old mice. In cardiomyocytes from 10-12 
month old Tg mice (hypertrophied and failing) APD90 was longer compared to Ntgs; 4- 
aminopyridine evoked spontaneous triggered activity and hearts revealed a very low 
basal contractility. At -140 mV no significant change was observed between Tg and Ntg 
cells in the inwardly rectifying potassium current. The Ito up-regulation may exert a com- 
pensatory function for the high Ca 2+ induced prolongation of APD. At 10-12 months the 
Tg mice showed a slight decrease (41.4%±6.9, P<0.05, n=3) in Kv4.2 consistent with a 
decrease in Ito. 
Conclusion: This study demonstrates the complexity of ion current changes in a model 
of hypertrophy and failure, and the difficulty of using the APD as a hallmark of cardiac 
hypertrophy. The data also suggest that increased [Ca2+]i may be an important factor not 
only in triggering disease but in electrical remodeling. 
1181-143 A Novel Efficient Percutaneous Myocardial Gene 
Del ivery System 
Ronen BeerL Luis J. Guerrero, Suzanne Sullivan, Gregory Supple, Robert A. Levine, 
Roger J. Hajjar, Massachusetts General Hospital, Boston, Massachusetts. 
Manipulating gene expression in the failing heart has therapeutic promise, but up to now 
efficient and homogeneous cardiac gene delivery has required an open-chest approach. 
Critical conditions to maximize percutaneously delivered gene expression include pro- 
longing the exposure to the viral vector and enhancing its myocardial uptake across the 
end(~thelial barrier, Ultrasound-induced disruption of echo contrast microbubblas 
enhances endothelial crossing. We planned to maximize vector delivery with bubbles by 
injection into the aortic root with brief balloon occlusion above the sinuses, while prolong- 
ing diastole and vasodUating with acetylchotine (ACh). 
Methods: In 20 male rats an angioplasty balloon catheter was positioned just above the 
aortic valve via the right carotid artery. The LV was imaged in long axis view with an 
esophageal echo catheter (AcuNav). in 5 rats, the balloon was inflated and 1.5 ~g ACh 
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injected, followed by a 0.25 ml echo contrast suspension (Optison) pre-incubated with 
adenovirus encoding the ~Gal reporter gene under control of the CMV promoter. When 
asystole occurred (no longer than 1 sac) and the myocardium filled with contrast, the 
echo mechanical index (MI) was raised to disrupt the bubbles, and the balloon deflated. 
When myocardial contrast depletion was noted, the MI was lowered to allow replenish- 
ment, and repeatedly raised until no more contrast appeared. Five rats received vector 
and Optison without he delivery mechanism (ACh and balloon); 5 received vector alone 
with delivery system; 5 controls received no virus. The rats were sacrificed 5 days later 
and gene expression assessed by xGal colorimetric assay. 
Results: The delivery system increased myocardial gene expression for virus+Optison 
by >2.5-fold, from 925±166 to 2358±376 (P<.01). The delivery system a~so produced 
substantial expression with vector alone (1473±549, compared with control values of 
433±332, P<.05). 
Conclusions: An adenoviral delivery system which combines echo contrast with a cath- 
eter-based technique to maximize coronary perfusion increases gene delivery compared 
with echo contrast alone. This novel method permits efficient percutanecus gene delivery 
in closed-chest animals. 
1181-144 Assessment of the Myocardial Trenscr iptome in Heart 
Failure Using Redundant Cross-Species 
Ol igonucleotlde Arrays 
Sarfraz A. Durrani, Thomas P. Cappola, Brian Rah, Eric Hoffman, Joshua M. Hare, 
NHLBI Program in Genomic Appiications-HopGene, Johns Hopkins Universi~ 
Baltimore, Maryland, Center for Genetic Medicine, Children's National Medical Center, 
Washington, Dist. of Co/umbia. 
Background: Although myocyte hypertrophy is a characteristic feature of congestive 
heart failure, the signals and transcriptional changes that mediate hypertrophy are com- 
plex and redundant, in order to fully understand heart failure pathogenesis, multiple path- 
ways must be studied simultaneously. Oligonucleotide array technology provides a 
platform for these experiments, but it is limited to only a few species. Here we report the 
cross-speciss use of human, muscle-specific oligonuctsotide arrays to elucidate tran- 
scriptional changes associated with heart failure in canine pacing-induced cardiomyopa- 
thy. 
Methods: Heart failure was induced in male mongrel dogs by ventricular pacing (210 
bpm for 3 weeks and 240 bpm for 1 week). RNA was isolated from left-ventricular f ee 
wall myocardium obtained from paced and control unpaced dogs (n=3 each, cesium 
chloride gradient method). Within each group, samples were combined in equimolar 
amounts resulting in single failing and control RNA pools. Duplicate in vitro transcriptions 
were performed on each pool to form 2 failing and 2 control cRNA probes that were each 
hybridized with a customized human Affymetrix muscle chip (4601 probe sets; 32-96 oli- 
gos or 2-3 probe sets/gene). Over- and under-expressed genes were selected using 
GeneChip software. 
Results: 500 (-25%) of the -2000 genes were detected. Of these 500 genes, 10 were 
over-expressed and 3 were under-expressed in heart failure. While many of the upregu- 
lated genes were novel, most belonged to established metabolic pathways: signal trans- 
duction (G protein ~S-21 caveolin-3); calcium handling (calumenin); growth and 
remodeling (preprom?.(I) collagen, ¢¢2-actinin, connective tissue growth factor); energy 
metabolism (brain creatine kinase, aconitase 2) and oxidative stress (diaphorese). 
Conclusions: Pacing-induced heart failure is accompanied by large transcriptional 
changes in genes related to calcium handling, receptor-mediated signal transduction, 
energy metabolism, and oxidative stress, as well as several novel genes. These results 
validate the cross-species use of oligo-nucleotide arrays, and provide novel targets for 
further studies of heart failure pathogenesis. 
1181-145 Hemodynamic Assessment of Septic Mice Deficient in 
Inducible Nitric Oxide Syntheae Demonstrates 
Improved Myocardial Performance 
Staven M. Hollenbero, Andrew Dumasius, Mohammed Khamis, Joseph E. ParriUo, Rush 
Medical College, Chicago, Idaho. 
Introduction: Vasodilation and myocardial depression characteristic of septic shock may 
result from overproduction of nitric oxide, and can lead to pressor-refrectory hypotension 
and death. To evaluate the significance of cytokine-inducible nitric oxide synthase (iNOS) 
in the pathogenesis of sepsis, we measured hemodynamics in resuscitated septic wild- 
type ,(WT) and iNOS-deficient mice. 
Methods: Mice were made septic by cecal ligation and puncture (controls underwent 
sham llgation) and were resuscitated with fluids (50 ml/kg SQ) and antibiotics (ceftriax- 
one and clindamycin IM) every 6 hours. Echocardiography was performed at 6 hour inter- 
vals for 48 hrs on unanesthetized, restrained mice. 
Results: In controls, (n=6) mean heart rate (HR, WT 457¢29, iNOS-deficient 480±53 
bpm), stroke volume (SV, WT 23±3, iNOS-deficient 22¢3 pL), cardiac output (CO, WT 
10.4±1.2, iNOS-def 10.3±1.6 ml/min), and fractional shortening (FS, WT 0.53±0.07, 
iNOS-deficient 0.55±0.07) did not change significantly over 48 hours, in WT septic mice 
(n=9), HR and CO increased by 10*15% (from 498±37 to 542±60 bpm and 10.6±1.9 to 
12.4±2.2 ml/min), peaking at 24-30 hours; SV (23±5 p.L) and FS (0.54±0.07) were 
unchanged. In iNOS-deficisnt septic mice, (n=12) FS increased significantly at 24-30 
hours (0.54±0.05 to 0.62¢0.05, p<0.03 vs baseline and p<0,01 vs WT), with slightly 
larger increases in CO (10.7±2.4 to 13.3¢5.4 ml/min, p=0.07) and SV (23±5 to 25±8 p.L, 
p--0.3). End-diastolic dimension increased (3.04±0.30 vs 3.28±0.15 ram, p=0.03) and 
end-systolic dimension decreased (1.47±0.23 vs 1.33±0.28 mm, p--O.2). 
Conclusions: iNOS-deficient septic mice had a more hyperdynamic response with 
increased fractional shortening in an awake, fluid-resuscitated, antibiotic-treated model 
that replicates the mortality and hyperdynamic state seen in clinical sepsis. This sug- 
gests that iNOS-induced NO has an important pathogenic role in producing myocardial 
depression in septic shock. 
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1182-153 Detection of Myocardial Infarction In Heart Failure 
Patients With Severe Left Ventrlcular Systolic 
Dysfunction by Contrast Enhanced MRI 
David Bello. Carolina Karam, Michelle Parker, George Farah, John Vargas, Robert M. 
Judd, Robert O. Bonow, Mihai Gheorghiade, Raymond J. Kim, Northwestern University 
Medical School, Chicago, Illinois. 
Background: Contrast-enhanced Magnetic Resonance imaging (CE-MRI) can visualize 
both transmural and subendocardial myocardial infarction. Most clinical trials classified 
cardiomyopathy as ischemic (ICM) based on one or more of the four following criteria: 
history or clinical evidence of prior myocardial infarction (MI); significant coronary steno- 
sis on coronary angiography; prior revascularizafion, or an abnormal functional stress 
test. Patients who do not meet these criteria are classified as nonischemic (NICM). This 
study investigated the use of CE-MRI to identify evidence of prior myocardial infarction in 
patients with severe left ventricular dysfunction of mixed etiologies. 
Methods: Cine and CE-MRI were performed on 43 patients with severe left ventricular 
dysfunction. 27 (83%) were classified as ICM (LVEF:23+10) and 16 (37%) as NICM 
(LVEF:32~11). Wall motion and the trensmural extent of hyperenhancement (HE) repre- 
senting prior infarction were scored by two blinded observers using a 72 segment model. 
Results: All 27 pts with criteria for ICM demonstrated HE, despite the fact that 13 pts 
(48%) of the ICM pts had no history or clinical evidence of prior MI. in contrast 2/16 pts 
(I 3%) with NICM demonstrated HE; one patient had sercoidosis and the other idiopathic 
cardiomyopathy. For ICM pts, 86%of all segments were dysfunctional whereas for NICM 
pts, 77% were dysfunctional (p=0.20). HE was present in 41% of all segments for ICM 
pts whereas for NICM pts, RE was present only in 4% of segments (p<O.0001); transmu- 
ral HE was seen in 7% of the segments among ICM whereas only 0.2% of NICM pts had 
evidence of transmurel HE (p<0.0005). 
Conclusions: In heart failure patients, 100% of patients with severe left ventricular dys- 
function satisfying criteria for ICM have evidence of prior MI as identified by contrast- 
enhanced MRI, whereas only 50% of such pts have a history or clinical evidence of prior 
MI. In addition, 13% of pts with non-ischemic ardiomyopathy have evidence or prior MI. 
1182-154 PreinfarcUon Angina Preserves the Right Ventrlculer 
Systolic Function in Acute Right Ventrlcular Myocardial 
Infarction 
Hideaki Yeshiq9, Eisei Kechi, Masato Taniuchi, Hisashi Shimizu, Kazuhiko Miyayama, 
Kyorin University, Tokyo, Japan. 
Background: Although preinfarction angina (PIA) protects left ventricular function in acute 
anterior myocardial infarction (MI), its effect on right ventricular (RV) systolic function is 
unknown. The purpose of the study is to evaluate the effect of PIA on RV dysfunction 
associated with an inferior MI. 
Methods: One hundred thirty consecutive patients with an acute inferior MI in whom 
angiography confirmed the location of the infarct-related lesions (IRL) and in whom RV 
function could be assessed during the acute phases using a rapid-measuring Swan- 
Ganz catheter participated in this study. The patients were divided into the following three 
groups according to the IRL site: right coronary artery (RCA) #1 (Prox-RCA group, n=52), 
RCA #2 or #3 (Mid-RCA group, n=53), and RCA #4 & distal or left circumflex artery (Dis- 
tal group, n=25). During the acute phase, the RV ejection fraction was measured. Angina 
within 1 week of MI was defined as PIA. 
Results: The acute RV ejection fraction was significantly decreased in the Prox-RCA 
group compared with the Mid-RCA and Distal groups (30.8 ± 9.9% vs. 36.4 ± 10.4% vs. 
39.7 ± 11.1%, P=0.0009). Among the patients with a complete RCA occlusion, the RV 
ejection fraction was significantly ~ower in the Prox-RCA and Mid-RCA groups than in the 
spontaneously recanalized patients (Prox-RCA group: 29.2 ± 10.1% vs. 35.5 ± 7.7%, 
P=0.0474; Mid-RCA group: 33.8 ± 9.4% vs. 40.8 ± 10.8%, P=0.0176). Of 105 patients in 
the Prox-RCA and Mid-RCA groups, 37 patients had PIA. The RV ejection fraction was 
significantly lower in the Prox-RCA group with PIA than without PIA (27.4 ± 9.2% vs. 36.7 
± 8.1%, P=0.0006). Among the Prox-RCA and Mid-RCA groups, multivariate analysis 
revealed that the site of IRL and occlusion of IRL were significant predictors for RV ejec- 
tion fraction (P=0.0002). Among the Prox-RCA group, the absence of PIA is the single 
determinant predictor for depressed RV function (P=0. 0025). 
Conclusion: The presence or absence of PIA is the major determinant predictor for RV 
systolic function in patients with a complete proximal RCA occlusion. 
1182-1 55 Relationship Between Microvaeculature Damage and 
Myocardial Inotropic Reserve in Patients With Stunning 
and in Patients With Nonviable Myocardlum After 
Pr imary PTCA for Acute Myocardial Infarction 
Philieoe Garct. Olivier Pascal, Jean-Luc Monin, Marc Simon, Patrick Dupouy, Emmanuel 
Teiger, Jdr6me Garot, Pascal Gu~ret, Jean-Luc Dubois-Rand~, Hopital Henri Mender, 
Creteil, France. 
Background: Coronary re-opening during AMI may provide microvasculature damage 
and consequently enhance myocardial dysfunction. We aimed to serially study microvas- 
colature function and to analyse its relationship to inotropic reserve (myocardial viability). 
Methods and results: Twenty-one pts who exhibited persistent regional LV dysfunction 
despite successful primary PTCA (TIMI-3 flow, residual stenosis < 30%) for a first AMI, 
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